Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
A groundbreaking genetic test could soon help identify children at a higher risk of becoming obese in adulthood.
A comprehensive global study published in Nature Medicine has revealed that severe obesity in adulthood can be predicted from early childhood through the use of a polygenic risk score, commonly referred to as PGS.
This PGS functions as a sophisticated calculator that aggregates the effects of various genetic risk variants that an individual may possess, according to researchers involved in the study.
According to a press release from the University of Copenhagen’s Novo Nordisk Foundation Center for Basic Metabolic Research, the test can effectively be administered to children as young as five, well before noticeable weight changes occur.
Researchers believe that early identification via the PGS could bolster preventive strategies against obesity, including tailored lifestyle interventions initiated at younger ages.
The study concludes that the implementation of PGSs may significantly enhance the accuracy of obesity predictions, particularly when utilized early in life.
Roelof Smit, the lead author and an assistant professor at the Novo Nordisk Foundation Center, emphasized the immense potential of the PGS due to its capability to foresee adult obesity long before other risk factors start influencing weight during childhood. He noted that intervening at this early stage can lead to a profound impact on children’s health.
The in-depth study marked a major collaboration among over 600 scientists from more than 500 global institutions, including the consumer genetics and research company 23andMe, Inc.
The researchers compiled genetic data from over five million individuals, thereby creating what is characterized as the largest and most diverse genetic dataset in recorded history. This extensive dataset facilitated the formulation of the PGS.
The findings demonstrated that the PGS was significantly more effective than previous tests, being twice as accurate in predicting obesity risk, as it accounted for around 17.6 percent of a child’s probability of developing a high body mass index as an adult.
According to Ruth Loos, a professor from the Center at the University of Copenhagen and co-author of the study, this new polygenic score marks a substantial enhancement in predictive capabilities. She described it as a significant advancement in the genetic forecasting of obesity risk, moving the field closer to practical and clinically applicable genetic testing.
Additionally, the research uncovered that individuals at a higher genetic risk of obesity demonstrated greater responsiveness to lifestyle weight-loss interventions. However, there is a caveat; these individuals tended to regain lost weight more rapidly once such interventions ceased.
It is important to note that while the PGS shows promising predictive power, its efficacy has limitations. The researchers acknowledged that the scoring system proved to be more accurate for individuals with European ancestry compared to those with African ancestry, highlighting the need for further refinement and research.
These findings underscore the potential significance of genetic insights in combating obesity. By implementing this advanced genetic testing earlier in childhood, healthcare providers might better tailor interventions to suit individual risk profiles. This proactive approach could serve as an essential tool in the ongoing fight against obesity, a condition that affects millions worldwide.
In summary, as science continues to unveil the complexities of genetic influences on obesity, tools like the polygenic risk score are poised to transform public health strategies. Armed with this knowledge, parents and healthcare professionals can take decisive actions to foster healthier generations.
